Viatris
  • Über Viatris
    • Unser Anliegen
    • Unsere Reise
    • Unsere Führungskräfte
    • Unternehmensverant- wortung
    • Transparenz
    • Gesundheitspolitik
    • Partnerschaft
    • Global Healthcare Gateway
  • Produkte
    • Produkte Viatris Pharma GmbH
    • Produkte Mylan Pharma GmbH & MEDA Pharma GmbH
    • Unerwünschte Ereignisse und medizinische Anfragen
  • News
    • Press Releases
  • Kontakt
    • Karriere
    • Dokumente
  • Investoren
    • Veranstaltungen und Präsentationen
    • Finanzdaten und Veröffentlichungen
    • Aktieninformationen
    • Toolkit für Aktionäre
    • Fragen und Antworten für Investoren
Show Menu
Change LocationDE
Deutsch (Schweiz)
  • Deutsch (Schweiz)
  • français (Suisse)
Choose Your Location
Global Visit our Corporate site
  • Australia
    • Austria
      • Belgium
        • Dutch
        • French
      • Brazil
        • Bulgaria
          • Canada
            • English
            • French
          • China
            • Croatia
              • Czech Republic
                • Denmark
                  • Finland
                    • France
                      • GermanyGermany
                        • Greece
                          • Hong Kong
                            • Hungary
                              • India
                                • Ireland
                                  • Italy
                                    • Japan
                                      • Korea
                                        • Malaysia
                                          • Mexico
                                            • Netherlands
                                              • New Zealand
                                                • Norway
                                                  • Poland
                                                    • Portugal
                                                      • Romania
                                                        • Russia
                                                          • Saudi Arabia
                                                            • Serbia
                                                              • Slovakia
                                                                • Slovenia
                                                                  • South Africa
                                                                    • Spain
                                                                      • Sweden
                                                                        • Switzerland
                                                                          • German
                                                                          • French
                                                                        • Taiwan
                                                                          • Thailand
                                                                            • Türkiye
                                                                              • United Kingdom
                                                                                • United States

                                                                                    Sie sind im Begriff Viatris.ch zu verlassen

                                                                                    Sie verlassen jetzt Viatris.ch und wechseln zu einer Website einer Viatris-Konzerngesellschaft oder eines Drittanbieters. Diese sind jeweils allein für den Inhalt ihrer Seiten verantwortlich, einschließlich der Einhaltung der lokal geltenden gesetzlichen Regelungen. Links zu Websites von Viatris-Konzerngesellschaften oder Drittanbietern werden unseren Besuchern als Service zur Verfügung gestellt. Diese Seiten unterliegen möglicherweise nicht den gleichen rechtlichen Anforderungen, die für diese Website gelten. Außerdem unterliegen Websites von Drittanbietern ihren eigenen Nutzungsbedingungen sowie Datenschutzregelungen und -praktiken. Wenn die Websites von Drittanbietern darüber hinaus den Gesetzen anderer Länder unterliegen, können sich behördliche Auflagen, Datenschutzbestimmungen oder medizinische Behandlungspraktiken je nach Land unterscheiden und die darin enthaltenen Informationen sind möglicherweise nicht für die Nutzung in Ihrem Land geeignet.

                                                                                    Weiter
                                                                                    Abbrechen
                                                                                    1. ←
                                                                                    2. Über Viatris
                                                                                    3. Unsere Führungskräfte

                                                                                    Rajiv Malik

                                                                                    President


                                                                                    Rajiv Malik is president of Viatris and a member of the company’s board of directors. He has more than 36 years of experience in the pharmaceutical industry. He is responsible for the day-to-day operations of Viatris, overseeing the company’s commercial business units, the Commercial Development, Medical, IT and Quality functions, as well as R&D and Operations.

                                                                                    Malik's unique leadership profile combines scientific, operational and commercial expertise, strong financial acumen and a global perspective on healthcare challenges.

                                                                                    Previously Malik served as president of Mylan, where he led the company’s global commercial, scientific, operational as well as information technology and business development activities in more than 165 countries and territories. He oversaw operations that managed a portfolio of more than 7,500 products, a pipeline of approximately 1,200 products and more than 40 manufacturing facilities around the world. He also served on the Mylan Board of Directors.

                                                                                    Building on this experience and expertise, Malik’s strategic vision and leadership played a key role in integrating Mylan and Upjohn, formerly a division of Pfizer, to form Viatris and he will play an integral role in driving the company to move up the value chain with more focus on complex science.

                                                                                    Throughout his time at Mylan, Malik held additional various senior roles, including executive vice president and chief operating officer from July 2009 to December 2012, and head of Global Technical Operations from January 2007 to July 2009. Malik was integral in helping to develop the strategies for the company’s acquisitions over more than the past 10 years and, importantly, in the execution and integration of acquisitions. During the company’s growth period, he maintained a keen focus on the innovative segments of the industry's value chain, including inhaled respiratory products, complex injectables and complex generics like glatiramer acetate. He also focused on building an industry-leading biosimilars portfolio and the development of new chemical entities (NCEs), all while ensuring a core commitment to improving patient access to medicines around the world.

                                                                                    Malik joined Mylan in January 2007, when Mylan acquired a controlling stake in Matrix Laboratories Limited (now Mylan Laboratories Limited), where Malik served as chief executive officer from July 2005 to June 2008.

                                                                                    Prior to joining Matrix, he served as head of Global Development and Registrations for Sandoz GmbH and head of Global Regulatory Affairs and head of Pharma Research for Ranbaxy. Malik earned his master's degree in pharmaceutical technology from Punjab University, India, and has more than 60 process patents to his credit.

                                                                                    • Datenschutzhinweis von Viatris
                                                                                    • Cookie-Hinweis von Viatris
                                                                                    • Nutzungsbedingungen
                                                                                    • California Supplemental Disclosure
                                                                                    • California Supply Chain Transparency, UK and Australia Modern Slavery Statement
                                                                                    • Datenschutzhinweis von Viatris
                                                                                    • Cookie-Hinweis von Viatris
                                                                                    • Nutzungsbedingungen
                                                                                    • Über Viatris
                                                                                    • California Supplemental Disclosure
                                                                                    • California Supply Chain Transparency, UK and Australia Modern Slavery Statement
                                                                                    • Kontakt
                                                                                    • Produkte
                                                                                    • Impressum
                                                                                      • Follow Us

                                                                                      Visit our Corporate site

                                                                                      Viatris
                                                                                      © 2023 Viatris Inc. All Rights Reserved. VIATRIS, the Viatris Logo and the Global Healthcare Gateway logo are trademarks and GLOBAL HEALTHCARE GATEWAY and PARTNER OF CHOICE are registered trademarks of Mylan Inc., a Viatris company.